Nebracetam
Izgled
(Preusmjereno sa stranice LCAFGJGYCUMTGS-UHFFFAOYSA-N)
(IUPAC) ime | |||
---|---|---|---|
(RS)-4-(aminometil)-1-benzilpirolidin-2-on | |||
Klinički podaci | |||
Identifikatori | |||
CAS broj | 97205-34-0 | ||
ATC kod | nije dodeljen | ||
PubChem[1][2] | 65926 | ||
ChemSpider[3] | 59334 | ||
UNII | T30038QI8N | ||
Hemijski podaci | |||
Formula | C12H16N2O | ||
Mol. masa | 204,268 g/mol | ||
SMILES | eMolekuli & PubHem | ||
| |||
Farmakoinformacioni podaci | |||
Trudnoća | ? | ||
Pravni status | Nije kontrolisan | ||
Način primene | Oralno |
Nebracetam je nutropski iz racetamske familije, i antidepresiv (agonist M1 acetilholinskog receptora).[4]
- ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.
- ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
- ↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.
- ↑ Satoshi Takeo, Hideki Hayashi, Keiko Miyake, Kaori Takagi, Mina Tadokoro, Norio Takagi, Sayuri Oshikawa (May 1997). [onlinelibrary.wiley.com/doi/10.1038/sj.bjp.0701161/full „Effects of delayed treatment with nebracetam on neurotransmitters in brain regions after microsphere embolism in rats”]. British Journal of Pharmacology 121: 477–484.